Details About Generic Salt ::  Oseltami

Main Medicine Class:: Anti-infective,Antiviral   

(oh-sell-TAM-ih-veer)

Tamiflu

Class: Anti-infective/Antiviral

 

Drugs Class ::

 Action Inhibition of influenza virus neuraminidase with possible alteration of virus particle aggregation and release.

Indications for Drugs ::

 Indications Treatment of uncomplicated acute illness caused by influenza infection in patients > 1 yr who have been symptomatic for £ 2 days; prophylaxis of influenza in patients ³ 13 yr.

Drug Dose ::

 Route/Dosage

Treatment of Influenza

ADULTS AND ADOLESCENTS ³ 13 YR: PO 75 mg twice daily for 5 days. Renal impairment (Ccr 10 to 30 mL/min): PO 75 mg once daily for 5 days. ADULTS AND CHILDREN ³ 1 YR (who cannont swallow capsules): Suspension PO £ 15 kg (£ 33 lbs) administer 30 mg (2.5 mL) twice daily. > 15 to 23 kg (> 33 to 51 lbs) administer 45 mg (3.8 mL) twice daily. > 23 to 40 kg (51 to 88 lbs) administer 60 mg (5 mL) twice daily > 40 kg (> 88 lbs) administer 75 mg (6.2 mL) twice daily.

Influenza Prophylaxis

ADULTS AND ADOLESCENTS ³ 13 YR: PO 75 mg once daily for ³ 7 days. Renal impairment (Ccr 10 to 30 mL/min): PO 75 mg every other day.

Contraindication ::

 Contraindications Standard considerations.

Drug Precautions ::

 Precautions

Pregnancy: Category C. Lactation: Undetermined. Children: Influenza treatment: Safety and efficacy not established in children < 1 yr. Influenza prophylaxis: Safety and efficacy not established in children < 13 yr. Repeated courses: Safety and efficacy not established. Renal impairment: Administer with caution.

PATIENT CARE CONSIDERATIONS

Drug Side Effects ::

 Adverse Reactions

RESP: Bronchitis. CNS: Insomnia; vertigo. GI: Nausea; vomiting.

Drug Mode of Action ::  

 Action Inhibition of influenza virus neuraminidase with possible alteration of virus particle aggregation and release.

Drug Interactions ::

 Interactions None well documented.

Drug Assesment ::

 Assessment/Interventions

• Obtain patient history, including drug history and any known allergies.
• Monitor patient for potential hypersensitivity.
• Monitor for adverse events including nausea, vomiting, and diarrhea.

OVERDOSAGE: SIGNS & SYMPTOMS   Nausea, vomiting

Drug Storage/Management ::

 Administration/Storage

• Store at room temperature in a dry, closed container out of the reach of children.
• Administer within 2 days of the onset of symptoms.
• Administer with or without food.
• Food has increased tolerability for some patients.

Drug Notes ::

 Patient/Family Education

• Instruct patient to begin treatment as soon as possible at the first appearance of flu symptoms.
• Instruct patient of the importance of nonpharmacological therapies such as adequate hydration and rest.
• Instruct patient to take oseltamivir as directed and to take any missed doses as soon as remembered unless it is within 2 hr before the next scheduled dose, and then continue to take oseltamivir at the usual scheduled times.
• Teach patient that oseltamivir is not a substitute for a flu vaccination, and to continue to receive an annual flu vaccination.
• Advise patient to notify physician immediately if pregnant, planning to become pregnant, or planning to breastfeed.

Disclaimer ::

The Information available on this site is for only Informational Purpose , before any use of this information please consult your Doctor .Price of the drugs indicated above may not match to real price due to many possible reasons may , including local taxes etc.. These are only approximate indicative prices of the drug.